pharmaphorum

MARCH 15, 2022

Sanofi has agreed a deal with life sciences investor Blackstone to help fund clinical trials of a new formulation of Sarclisa for blood cancer multiple myeloma, accelerating its development. Sanofi has partnered with drug delivery specialist Enable Injections to develop the subcutaneous formulation.

Trials 92

Trials Sales Drug Delivery Antibody 92

The Pharma Data

SEPTEMBER 11, 2020

Starpharma experimenting with Gilead’s antiviral drug for easier administration. Melbourne-based Starpharma has announced it has applied its novel DEP drug delivery technology to create a long ? acting, water-soluble version of remdesivir. Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

Delveinsight

NOVEMBER 29, 2020

Therapies such as dexamethasone drug delivery system and vascular endothelial growth factor inhibitors have already pierced deeper into the market. BioSeizer formulation of dexamethasone sodium phosphate (DSP), TLC399 is an intravitreal, or in-eye, injection, and is under a larger randomized, double-blind, dose-finding phase II trial.

Marketing 52

Marketing Pharma Companies Drug Delivery Clinical Trials 52

XTalks

MAY 23, 2024

XTALKS WEBINAR: Enhancing Efficiency in Early-Phase Oncology Trials: Strategies for Accelerating Data Flow Live and On-Demand: June 24, 2024, at 11am EDT (4pm BST/UK) Register for this webinar today to gain insights into how you can navigate and overcome data flow challenges in early-phase oncology clinical trials.

Life Science 72

Life Science Dermatology Drug Delivery Systems Medicine 72

The Pharma Data

JANUARY 3, 2021

The strategic move to partition lung disease programs from TLC will allow TLC to maintain focus on its current pipeline of liposomal injectable formulation programs, such as TLC599 for osteoarthritis pain and TLC590 for postsurgical pain, while instilling to InspirMed funding designated for use in the development of inhalable drugs.

Clinical Trials 52

Clinical Trials Clinical Trials Containment Development 52

The Pharma Data

DECEMBER 17, 2020

The trial remains on-track to complete enrollment of all 500 patients in the United States and Australia before the end of 2020, despite the worsening of the COVID-19 pandemic. In its Phase II clinical trial, TLC599 significantly reduced pain at and through every scheduled visit through six months.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Containment 40

The Pharma Data

DECEMBER 27, 2020

We remain confident that results from this trial will be positive given the outstanding results observed in our Phase II clinical trial.”. million people misused prescription opioids in 2018, and many die every day from opioid-related drug overdoses. SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Dec.

Trials 40

Trials Clinical Trials Clinical Trials Containment 40

The Pharma Data

MARCH 15, 2022

For the Sarclisa ® subcutaneous formulation delivery, Sanofi has partnered with drug delivery technology innovator company Enable Injections , Inc. to advance the development of a subcutaneous delivery for Sarclisa ® with the goal of offering a unique patient-centric treatment experience. In the U.S.,

Life Science 52

Life Science Antibody Clinical Trials Clinical Trials 52

The Pharma Data

JUNE 26, 2021

Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA), under Priority Review, for Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD). Roche (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S.

Drug Delivery 52

Drug Delivery Clinical Trials Clinical Trials Medicine 52

Delveinsight

JULY 30, 2021

While Humira still has a year or two to spare owing to its expected patent expiry in the year 2023 in the US, the drug has already been off-patent in the EU. However, the market growth is expected to face a threat from an inescapable entry of biosimilars in the approaching years.

Marketing 74

Marketing Drug Delivery Development Clinical Trials 74

The Pharma Data

JANUARY 17, 2021

a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced dose administration for the first patient in a Phase 2a clinical study of the company’s lead drug candidate, STP705, for the treatment of cutaneous basal cell carcinoma.

Gene Expression 52

Gene Expression Trials Production Development 52

The Pharma Data

JANUARY 3, 2021

The Company’s pipeline leverages its proprietary bioerodible Durasert® technology for extended intraocular drug delivery including EYP-1901, a potential six-month sustained delivery intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration.

Production 52

Production Sales Development Licensing 52

The Pharma Data

APRIL 12, 2023

1 9 , 20 It develops when new and abnormal blood vessels grow uncontrolled under the macula, causing swelling, bleeding and/or fibrosis. 2 6 About the Vabysmo ® ( faricimab ) clinical development programme Roche has a robust phase III clinical development programme for Vabysmo.

Antibody 40

Antibody In-Vitro Development Trials 40